Cargando…

Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer

The objective of the current study was to investigate the impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer (NSCLC). In 115 archived NSCLC tissue samples, the expression of Brachyury was observed to be significantly higher than that in adjac...

Descripción completa

Detalles Bibliográficos
Autores principales:	XU, KE, LIU, BIN, LIU, YONGYU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438917/ https://www.ncbi.nlm.nih.gov/pubmed/25683840 http://dx.doi.org/10.3892/mmr.2015.3348

Ejemplares similares

Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
por: Du, Rui, et al.
Publicado: (2014)

Prognostic significance of expression of epithelial-mesenchymal transition driver brachyury in breast cancer and its association with subtype and characteristics
por: Lee, Kwan Ho, et al.
Publicado: (2018)

Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine
por: Hamilton, Duane H., et al.
Publicado: (2013)

MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition
por: David, Justin M., et al.
Publicado: (2016)

The Role of Transcriptional Factor Brachyury on Cell Cycle Regulation in Non-small Cell Lung Cancer
por: Xu, Jingyi, et al.
Publicado: (2020)

T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma
por: IMAJYO, IKUMI, et al.
Publicado: (2012)

The T-box transcription factor Brachyury regulates epithelial–mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells
por: Shimoda, Miyuki, et al.
Publicado: (2012)

Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma Cells
por: Skarkova, Veronika, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition Contributes to Docetaxel Resistance in Human Non-Small Cell Lung Cancer
por: Shen, Weiwei, et al.
Publicado: (2014)

MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer
por: Ma, Ke, et al.
Publicado: (2017)

Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression
por: Bagheri, Meisam, et al.
Publicado: (2023)

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)
por: Boyerinas, Benjamin, et al.
Publicado: (2013)

RBP2 Induces Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer
por: Wang, Shikun, et al.
Publicado: (2013)

Small-molecule targeting of brachyury transcription factor addiction in chordoma
por: Sharifnia, Tanaz, et al.
Publicado: (2019)

Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer
por: Wang, Biao, et al.
Publicado: (2017)

Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma
por: Feng, Fei, et al.
Publicado: (2017)

Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer
por: Hu, Yunping, et al.
Publicado: (2016)

Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer
por: Chen, Ying, et al.
Publicado: (2017)

Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells
por: Kyakulaga, Al Hassan, et al.
Publicado: (2018)

Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
por: Siddiqui, Mohammad Aarif, et al.
Publicado: (2020)

DNER promotes epithelial–mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer
por: Wang, Zhong, et al.
Publicado: (2020)

Synaptotagmin 7 in twist-related protein 1-mediated epithelial – Mesenchymal transition of non-small cell lung cancer
por: Liu, Xiao, et al.
Publicado: (2019)

MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer
por: Liu, Min-Xia, et al.
Publicado: (2014)

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
por: Qin, Haifeng, et al.
Publicado: (2015)

Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial–mesenchymal transition
por: Deng, Qiu-di, et al.
Publicado: (2021)

Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer
por: Zhou, Lei, et al.
Publicado: (2015)

PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer
por: Avasarala, Sreedevi, et al.
Publicado: (2015)

The Impact of Non-coding RNAs in the Epithelial to Mesenchymal Transition
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2021)

CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells
por: Lu, Xiangdong, et al.
Publicado: (2018)

Mechanism of epithelial-mesenchymal transition inhibited by miR-203 in non-small cell lung cancer
por: Huang, Weicong, et al.
Publicado: (2020)

SATB1 protein is associated with the epithelial-mesenchymal transition process in non-small cell lung cancers
por: Glatzel-Plucinska, Natalia, et al.
Publicado: (2021)

An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer
por: Lobb, Richard J., et al.
Publicado: (2023)

Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition
por: Sun, Ming, et al.
Publicado: (2014)

Neuropilin 1 modulates TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer
por: Ding, Zongli, et al.
Publicado: (2019)

Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1
por: Xu, Suyan, et al.
Publicado: (2020)

Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
por: Zhou, Yujuan, et al.
Publicado: (2016)

A Systematic Review of Mesenchymal Epithelial Transition Factor (MET) and Its Impact in the Development and Treatment of Non-Small-Cell Lung Cancer
por: Bodén, Embla, et al.
Publicado: (2023)

Quantitative Dissection of the Proximal Ciona brachyury Enhancer
por: Shimai, Kotaro, et al.
Publicado: (2022)

Bufalin inhibits epithelial-mesenchymal transition and increases radiosensitivity of non-small cell lung cancer via inhibition of the Src signaling
por: Wang, Zijian, et al.
Publicado: (2023)

Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
por: Heery, Christopher R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o2tlqqdv4h29o606bc8tlhsnnp